Colombian officials accidentally reveal details on Big Pharma’s immunity for adverse reactions to COVID vaccines
BOGOTA, Colombia (LifeSiteNews) – Officials in Colombia accidentally published contracts from both Pfizer/BioNTech and AstraZeneca, detailing the multimillion-dollar deals and indemnification agreements struck between the South American nation and the pharmaceutical giants to import around 25 million combined doses of their COVID-19 vaccines.
While attempting to transfer the confidential information to a regional court following a tutelage filing, Colombia’s Council of State, the supreme judicial authority in the country, mistakenly disclosed contracts signed between the Colombian government and the drug manufacturers on its publicly accessible judicial information system, an RT news report revealed.
Though the mistake was quickly discovered by the government and the documents removed from public access, the Colombia-based non-profit Anticorruption Institute was able to access and copy the information, and later published the leaked documents on its own website “to defend transparency and in a bid to safeguard the fundamental right of access to public information,” they argued.
The 132-page file details the contractual agreement established between the Colombian government and the two pharmaceutical companies, with AstraZeneca’s contract being signed on December 16, 2020, and Pfizer’s on February 2, 2021.
Colombian officials agreed to pay AstraZeneca $6 per dose, ordering a total of 9,984,000 shots from the Oxford-based operation and costing $59,904,000. Pfizer negotiated $12 per dose of their mRNA jab, selling the Colombians 15,000,570 shots totalling $180,006,840. All told, the Colombian government shelled out a hefty $239,910,840 for 24,984,570 doses of COVID-19 vaccines, corresponding to 12,492,285 citizens (around 25 percent of the population) being able to become “fully vaccinated” against the virus.
Meanwhile, vaccine injury firm Children’s Health Defense revealed that the U.S. paid $19.50 per dose of Pfizer’s mRNA jab for COVID-19.
But besides the eye-watering costs associated with importing the experimental jabs, the nation agreed to indemnify the manufacturers from any legal responsibility for adverse events arising from the use of their products.
Pfizer’s contract admitted that “Pfizer’s and BioNTech’s efforts to develop and manufacture the Vaccine are aspirational in nature and subject to significant risks and uncertainties,” and that, accordingly, “the Republic of Colombia will fully assume the risks derived from the acquisition, use and application of the vaccine.”
In fact, Pfizer explicitly stated that “the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known.” The Colombians were forced to acknowledge that the jab has unknown effects since it is “being rapidly developed due to the emergency circumstances of the COVID-19 pandemic.”
On account of the possibility of unknown adverse effects, the drug distributer demanded as part of the contract that Colombia “hereby agrees to indemnify, defend and hold harmless Pfizer, BioNTech, each of their Affiliates … based on the research, development, manufacture, distribution, commercialization or use of the Vaccine … from and against any and all suits, claims, actions, demands, losses, damages, liabilities, settlements, penalties, fines, costs and expenses … caused by, arising out of, relating to, or resulting from the Vaccine, including but not limited to any stage of design, development, investigation, formulation, testing, clinical testing, manufacture, labeling, packaging, transport, storage, distribution, marketing, promotion, sale, purchase, licensing, donation, dispensing, prescribing, administration, provision, or use of the Vaccine.”